Code used for the HER2-low breast cancer project of Shao Lab, Fudan Univerisity Shanghai Cancer Center (FUSCC).
Please cite: Dai, L.J. et al., Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer. Nature Communications. doi：10.1038/s41467-023-40715-x (2023).
Contributors: Lei-Jie Dai, Yu-Zheng Xu, Ding Ma, Yu-Wei Li.